Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK genetics and insurance committee established:

This article was originally published in Clinica

Executive Summary

The UK Department of Health has set up a Genetics and Insurance Committee in response to concerns over the use of genetic tests by insurers. Its terms of reference are to develop criteria for the evaluation of genetic tests, their application to particular conditions and their reliability and relevance to insurance; to evaluate tests against those criteria; and to report to government ministers on proposals from insurance providers and the level of compliance by industry with the committee's recommendations. Work has already begun on a mechanism to assess the use of tests for rare genetic disorders, including Huntington's disease.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT078258

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel